The world of targeted therapies in kidney cancers: pitfalls, tips and tricks
Sign Up to like & getrecommendations! Published in 2017 at "OncoTargets and therapy"
DOI: 10.2147/ott.s127919
Abstract: In the past few years, metastatic renal cell carcinoma prognosis was improved by the development of molecular targeted therapies (TTs). At the metastatic stage, the tolerance to treatment is a major concern, not only because… read more here.
Keywords: kidney cancers; world targeted; case; therapies kidney ... See more keywords
The Identification of Immunological Biomarkers in Kidney Cancers
Sign Up to like & getrecommendations! Published in 2018 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2018.00456
Abstract: The recent approval of several agents have revolutionized the scenario of therapeutic management of metastatic renal cell carcinoma (RCC) allowing us to reach important clinical end points with extended patients' survival. Actually, every new drug… read more here.
Keywords: rcc; identification immunological; biomarkers kidney; expression ... See more keywords
Signatures of Co-Deregulated Genes and Their Transcriptional Regulators in Kidney Cancers
Sign Up to like & getrecommendations! Published in 2023 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms24076577
Abstract: There are several studies on the deregulated gene expression profiles in kidney cancer, with varying results depending on the tumor histology and other parameters. None of these, however, have identified the networks that the co-deregulated… read more here.
Keywords: kidney cancer; kidney cancers; deregulated genes; expression ... See more keywords